Class action lawsuits
Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. after the company's shares dropped significantly following the termination of its partnership with Novo Nordisk due to unauthorized marketing and sale of compounded semaglutide drugs. The investigation focuses
Class action lawsuits
Purchasers of Hims & Hers Health, Inc. common stock between April 29, 2025, and June 23, 2025, both dates inclusive, may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The lawsuit claims that defendants made false and misleading statements about the
Class action lawsuits
Purchasers of securities of 3D Systems Corporation between August 13, 2024, and May 12, 2025, may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. A class action lawsuit has been filed against the company, alleging that it made false and/or
Class action lawsuits
Rocket Pharmaceuticals' securities class action lawsuit was filed for investors who purchased Rocket Pharmaceuticals securities between February 27, 2025 and May 26, 2025, due to alleged false and misleading statements made by the company about the safety and clinical trial protocol of its RP-A501 treatment. The lawsuit claims that
Class action lawsuits
Purchasers of 3D Systems securities between August 13, 2024, and May 12, 2025, are reminded of the important August 12, 2025, lead plaintiff deadline in the company's class action lawsuit. Investors may be entitled to compensation without payment of out-of-pocket fees or costs through a contingency fee arrangement.
Class action lawsuits
A class action lawsuit has been filed on behalf of investors who purchased American Depositary Shares ("ADSs") of Reckitt Benckiser Group PLC between January 13, 2021, and July 28, 2024, against the company for allegedly failing to warn investors about the increased risk of necrotizing enterocolitis ("NEC&
Class action lawsuits
Purchasers of securities of Organon & Co. (NYSE: OGN) between November 3, 2022 and April 30, 2025, may be entitled to compensation through a contingency fee arrangement. A class action lawsuit has already been filed, and the lead plaintiff deadline is July 22, 2025. Rosen Law Firm, a global investor
Class action lawsuits
Investors who purchased Fortrea Holdings, Inc. securities between July 3, 2023, and February 28, 2025, may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. A class action lawsuit has been filed, and a lead plaintiff must be selected to move the
Class action lawsuits
The lawsuit alleges that Centene Corporation misled investors by providing positive statements while concealing the true state of the company's enrollment and morbidity rates. The alleged securities fraud occurred between December 12, 2024, and June 30, 2025, causing significant losses for investors. Centene's stock price plummeted
Class action lawsuits
A class action lawsuit has been filed against Rocket Pharmaceuticals, Inc., alleging that the company made materially false and misleading statements regarding its Phase 2 pivotal trial for RP-A501, an experimental therapy for Danon disease. The lawsuit claims that investors suffered substantial losses after the price of their shares crashed
Class action lawsuits
Rocket Pharmaceuticals, Inc. has been involved in a securities class action lawsuit, which alleges that the company and certain officers or directors have engaged in securities fraud or other unlawful business practices. The lawsuit concerns the company's gene therapy for Danon disease, RP-A501, and a serious adverse event
Class action lawsuits
Investors who purchased shares of Reddit, Inc. (NYSE: RDDT) between October 29, 2024, and May 20, 2025, are encouraged to contact the Gross Law Firm regarding possible lead plaintiff appointment in a class action lawsuit. The lawsuit alleges that during this period, Reddit's executives issued false and/or
